Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
14
Number of overlapping holdings
63.6%
% of PJP's 22 holdings also in IHE
40.0%
% of IHE's 36 holdings also in PJP
Overlap by Weight
Sector Drift (PJP minus IHE)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PJP |
Weight in IHE |
Overlap | |
|---|---|---|---|---|
 |
JOHNSON & JOHNSON | 6.0% | 23.5% | 6.0% |
|
ELI LILLY & CO | 6.0% | 21.8% | 6.0% |
|
PFIZER INC | 5.9% | 4.8% | 4.8% |
|
MERCK & CO. INC. | 5.6% | 4.3% | 4.3% |
 |
JAZZ PHARMACEUTICALS PLC | 3.6% | 2.8% | 2.8% |
Position Highlights (Non-Overlapping Exposures)
PJP Overweight Relative to IHE
|
ABBVIE INC | 6.2% |
|
AMGEN INC | 6.2% |
|
REGENERON PHARMACEUTICALS | 6.1% |
|
ABBOTT LABORATORIES | 5.6% |
|
GERON CORP | 4.8% |
|
UNITED THERAPEUTICS CORP | 4.3% |
|
GILEAD SCIENCES INC | 4.0% |
|
BIOGEN IDEC INC | 3.6% |
|
INNOVIVA, INC. | 3.5% |
|
LIGAND PHARMACEUTICALS-CL B | 3.4% |
PJP Underweight Relative to IHE
|
JOHNSON & JOHNSON | -17.5% |
|
ELI LILLY & CO | -15.9% |
|
VIATRIS, INC. | -4.9% |
|
ZOETIS INC | -4.5% |
|
BRISTOL-MYERS SQUIBB CO | -4.4% |
|
ROYALTY PHARMA PLC CLASS A | -4.4% |
|
CATALENT INC | -4.2% |
|
INTRA-CELLULAR THERAPIES INC | -2.9% |
|
ELANCO ANIMAL HEALTH, INC. | -2.5% |
|
ORGANON & CO. | -2.2% |